Pathologic Predictors of Treatment Response to Neo-adjuvant Chemotherapy for Invasive Lobular Breast Carcinoma.
Allina Health System, Virginia Piper Cancer Institute, Minneapolis, Minnesota.
Michaela
M
Tsai
Allina Health System, Virginia Piper Cancer Institute, Minneapolis, Minnesota.
Marsha
M
Finkelstein
Allina Health Laboratories, Hospital Pathology Associates, Minneapolis, Minnesota.
Tamera
T
Lillemoe
Allina Health Laboratories, Hospital Pathology Associates, Minneapolis, Minnesota.
Barbara
B
Susnik
Allina Health Laboratories, Hospital Pathology Associates, Minneapolis, Minnesota.
Erin
E
Grimm
Allina Health Laboratories, Hospital Pathology Associates, Minneapolis, Minnesota.
Sung-Hae
SH
Kang
Allina Health Laboratories, Hospital Pathology Associates, Minneapolis, Minnesota.
Caitlin
C
Kelly
Allina Health System, Virginia Piper Cancer Institute, Minneapolis, Minnesota.
Karen
K
Swenson
D001943:Breast Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D018275:Carcinoma, Lobular / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D016896:Treatment Outcome